YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Head and Neck Granulocytic Sarcoma With Acute Myeloid Leukemia: Three Rare Cases

dc.authorscopusid 56208434400
dc.authorscopusid 25930629300
dc.authorscopusid 55891957000
dc.contributor.author Çankaya, H.
dc.contributor.author Ugras, S.
dc.contributor.author Dilek, I.
dc.date.accessioned 2025-05-10T17:06:12Z
dc.date.available 2025-05-10T17:06:12Z
dc.date.issued 2001
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Çankaya H., Dept. Otolaryngology-Head/Neck Surg., Yuzuncu Yil University Tip Fakultesi, 65200 Van, Turkey; Ugras S., Dept. Otolaryngology-Head/Neck Surg., Yuzuncu Yil University Tip Fakultesi, 65200 Van, Turkey; Dilek I., Dept. Otolaryngology-Head/Neck Surg., Yuzuncu Yil University Tip Fakultesi, 65200 Van, Turkey en_US
dc.description.abstract We conducted a retrospective review of pathology files and hospital records and identified three unusual presentations of granulocytic sarcoma associated with acute myeloid leukemia (AML) of the head and neck. At least one mass was observed on the skin of all three patients. A 17-year-old boy had masses in each temporal region that were accompanied by bilateral facial paralysis. He was administered chemotherapy and radiotherapy, but he died of infection secondary to a second relapse 29 months after the initial diagnosis. A 17-year-old girl had a tumor in the right parotid area. She received chemotherapy, but she died of infection and bleeding 2 months after the initial diagnosis, A 33-year-old man had numerous tumors widely disseminated over his skin. He received chemotherapy and was in remission 12 months after the initial diagnosis, but he eventually relapsed and died. Granulocytic sarcoma can be localized in unexpected regions, including the head and neck. This tumor is very often misdiagnosed as a malignant lymphoma, which leads to delayed treatment and a poor outcome. Therefore, clinical and histopathologic findings should be evaluated before any diagnosis of malignant tymphoma is pronounced. Immunohistochemical stains should also be performed on patients with suspected granulocytic sarcoma, and aggressive chemotherapy or immunotherapy should be administered. We believe that high-dose chemotherapy can improve survival rates in granulocytic sarcoma associated with AML. en_US
dc.identifier.doi 10.1177/014556130108000410
dc.identifier.endpage 229 en_US
dc.identifier.issn 0145-5613
dc.identifier.issue 4 en_US
dc.identifier.pmid 11338646
dc.identifier.scopus 2-s2.0-0035058958
dc.identifier.scopusquality Q2
dc.identifier.startpage 224 en_US
dc.identifier.uri https://doi.org/10.1177/014556130108000410
dc.identifier.uri https://hdl.handle.net/20.500.14720/6349
dc.identifier.volume 80 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Medquest Communications LLC en_US
dc.relation.ispartof Ear, Nose and Throat Journal en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.title Head and Neck Granulocytic Sarcoma With Acute Myeloid Leukemia: Three Rare Cases en_US
dc.type Article en_US

Files